News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Expanded Knowledge about Human Metabolome Expected to Fuel Development of New Therapeutic Drugs and Medical Laboratory Tests

Pathologists and clinical laboratory professionals can expect to see new molecular test development as researchers develop new biomarkers in the wake of expanded knowledge of the genome-metabolome-diseasome correlates

One field of science that bears great potential for use in diagnostics and medical laboratory testing involves the human metabolome. Researchers are gaining more understanding of the genetic underpinnings of complex disease and drug response through metabolic pathways.

For example, scientists at the Wellcome Trust Sanger Institute (WTSI) in the United Kingdom have linked 145 genetic regions with more than 400 molecules involved in metabolism in human blood, a story in Genetic Engineering News recently reported. The resulting atlas of associations will enable identification of genes that could be targeted in the development of drugs and clinical laboratory test. (more…)

MIT Researchers Detect Cancer from Urine Specimens by Combining Synthetic Biomarkers with Paper-based Diagnostics

Pathologists and clinical laboratory managers may soon see this innovative combination of diagnostic technologies used in developing nations

There is now a technology that combines synthetic biomarkers with a paper-based urine test that can detect colorectal cancer and thrombosis in just a few minutes. Medical laboratory tests incorporating this diagnostic technology would be accurate, cheap, and simple enough to perform in developing countries.

Researchers at Massachusetts Institute of Technology (MIT) say that the new technology opens the door to development a cheap diagnostic tool for a range of noncommunicable diseases (NCD). This could revolutionize diagnostic testing of NCDs, with particular significance for developing countries. (more…)

Harvard Researchers Create Chip-based, Liquid Biopsy Device That Offers a Novel Way to Monitor Treatment of Ovarian Cancer Patients and Only Costs $1

The ATC Chip identifies ovarian cancer cells floating in ascites and may be useful for diagnosing other types of malignancies that involve ascites, like pancreatic cancer

Pathologists will be interested to learn that researchers at Harvard Medical School and Massachusetts General Hospital are developing a “liquid biopsy” technology specifically to enable point-of-care monitoring of the progress of patients undergoing treatment for certain types of cancers.

The goal is to develop a method that community hospitals can use to monitor treatment of ovarian cancer patients without the need for expensive medical laboratory equipment, noted a report published by Biosciencetechnology.com. Researchers estimate that their ‘liquid biopsy’ technology could cost as little as $1 per test when eventually cleared for use in clinical settings.
(more…)

Super-Fast Microscope Captures Circulating Tumor Cells with High Sensitivity and Resolution in Real Time

Pathology groups and clinical labs could use the world’s fastest camera to diagnose cancer at earlier stages

There’s a new optical microscope that can detect rogue cancer cells. It was developed by engineers at the University of California Los Angeles (UCLA). The achievement could create new diagnostic capabilities for pathology and clinical laboratory medicine.

New Instrument Detects Circulating Tumor Cells

The target for this new high-speed microscope are Circulating cancer tumor cells (CTC). CTCs are the precursors to metastasis and metastatic cancer accounts for about 90% of cancer mortalities. However, CTCs are difficult to find and identify. Among a billion healthy cells, only a minute number of CTCs exist. (more…)

New Way to Look at Tissue Biopsies: Beckman Institute Researchers Develop Low Cost, High-Speed and Stain-free Optical Technology That Could Displace Existing Histopathology Methodologies

Pathologists would gain new tool to diagnose cancer faster and more accurately, based upon stain-free analysis of tissue

Reading tissue biopsies with a new stain-free method could eventually help pathologists achieve faster and less subjective cancer detection. Should this technology prove viable, it would also displace many of the longstanding tissue preparation methodologies used today in the histopathology laboratory.

Credit a research team from the Beckman Institute at the University of Illinois (UI) Christie Clinic and at the UI campuses in Urbana and Chicago, with developing this new technology.

They call the technique Spatial Light Interference Microscopy (SLIM). According to a story reported by Futurity.org, the technique uses two beams of light.

(more…)

;